Symptom Monitoring and Management Intervention After CAR-T

The goal of this study is to refine and test a digital intervention named WAYPOINT to help patients monitor and manage symptoms after CAR-T therapy. The main question this study aims to answer is whether this intervention can be used as planned (i.e, feasible) and whether it is helpful and easy to use for both patients and clinicians (i.e., acceptable).

Patient Inclusion Criteria: * Adult patients (at least 18 years old) diagnosed with hematological cancer * Treated with CAR-T as standard of care at Massachusetts General Hospital * Ability to speak and read English to use WAYPOINT and respond to the questionnaires with minimal assistance requried from an interpreter or a family member Patient Exclusion Criteria: * Patients with a major untreated psychiatric or cognitive conditions which the treating clinician believe prohibits the ability to participate in study procedures Clinician Inclusion Criteria - Healthcare clinicians (e.g., physicians, nurses, advanced practice professionals) at the Massachusetts General Hospital who provide care for patients treated with CAR-T therapy Clinician Exclusion Criteria \- Not able to provide consent